Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD
Clinical trial NCT00383370 · COMPLETED
Trial details
- NCT number
- NCT00383370
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2007-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.